MELANOMA BRIDGE 2016
November 30th - December 3rd 2016
Sanjiv Agarwala
St. Luke's University Hospital and Temple University, Bethlehem, Pennsylvania
Paolo A. Ascierto
Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, National Cancer Institute "Fondazione G. Pascale" of Naples, Italy
Davide Bedognetti
Sidra Medical and Research Center, Doha, Qatar
Carlo Bifulco
Earle A. Chiles Research Institute, Robert W. Franz Cancer Research Center, Providence Portland Medical Center, Portland, Oregon
Gerardo Botti
National Cancer Institute "Fondazione G. Pascale" of Naples, Italy
Luigi Buonaguro
National Cancer Institute "Fondazione G. Pascale" of Naples, Italy
Gennaro Ciliberto
National Cancer Institute "Fondazione G. Pascale" of Naples, Italy
Sandra Demaria
Weill Cornell medical College, New York, NY
Reinhard Dummer
University of Zurich Hospital, Department of Dermatology, Zurich
Connie Duong
INSERM (National Institute of Health and Medical Research), Institut Gustave Roussy, Villejuif, France
Alexander Eggermont
Institut de Cancérologie Gustave Roussy, Villejuif, Paris-Sud, France
Soldano Ferrone
Massachusetts General Hospital, Boston, Massachusetts
Silvia C. Formenti
Department of Radiation Oncology, Weill Cornell Medical College, New York
Jerome Galon
INSERM (National Institute of Health and Medical Research), Paris, France
Claus Garbe
Division of Dermatologic Oncology Department of Dermatology Eberhard Karls University Tuebingen, Germany
Ruth Halaban
Department of Dermatology, Yale University School of Medicine, New Haven
Samir Khleif
Georgia Cancer Center, Augusta University, Augusta, Georgia
Celeste Lebbe
Dermatology, APHP Hopital Saint Louis, Paris France
Karl Lewis
Division of Medical Oncology, University of Colorado, Denver, CO, USA
Roger Lo
Melanoma Clinic in Dermatology Member, Jonsson Comprehensive Cancer Center David Geffen School of Medicine at UCLA, Los Angeles, California
Jason Luke
Department of Hematology/Oncology, University of Chicago Comprehensive Cancer Center Chicago, IL, USA
Alessandro Lugli
Institute of Pathology, University of Bern, Switzerland
Francesco M. Marincola
Sidra Medical and Research Center, Doha, Qatar
Giuseppe Masucci
Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden
Lluis Mir
CNRS, Université Paris-Sud and Institut de Cancérologie Gustave Roussy, Villejuif, France
Nicola Mozzillo
Department Melanoma and Soft Tissues, National Cancer Institute "Fondazione G. Pascale" of Naples, Italy
Willem W. Overwijk
Department of Melanoma Medical Oncology - Research, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas
Franck Pages
Service d'Immunologie Biologique, Hôpital Européen Georges Pompidou, Paris, France
Giuseppe Palmieri
Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy
Michael Postow
Memorial Sloan Kettering Cancer Center, New York
Igor Puzanov
Melanoma Section Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY
Paul Sondel
University of Wisconsin School of Medicine and Public Health, Milwaukee
David Frank Stroncek
Department of Transfusion Medicine, NIH Clinical Center, Bethesda, Maryland
Janis M. Taube
Johns Hopkins University SOM, Baltimore, Maryland
Alessandro Testori
Dermato-oncology Surgery Division, European Institute of Oncology, Milan, Italy
Per thor Straten
Department of Immunology and Microbiology, University of Copenhagen, Denmark
Magdalena Thurin
Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, NCI, NIH, Rockville, Maryland
Ena Wang
Sidra Medical and Research Centre, Doha, Qatar
Jennifer A. Wargo
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Hassane Zarour
University of Pittsburgh Cancer Institute Hillman Cancer Center, Pennsylvania
Laurence Zitvogel
Institut Gustave Roussy, Villejuif, Paris-Sud, France
For information please contact info@melanomabridge.org
